StockData
Lexicon Pharmaceuticals, Inc. logo

Lexicon Pharmaceuticals, Inc. (LXRX) stock

LXRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3087% above fair value
$1.78+0.03 (+1.71%)

Close on Nov 17, 2026Market cap $792.02MP/E –Yield –

Lexicon Pharmaceuticals operating margin

Operating margin is operating income as a percentage of revenue.

Lexicon Pharmaceuticals's operating margin for the twelve months ending Jun 30, 2026 was -131.4%. For fiscal 2025 it was -98.2%, against -634.2% the year before. The highest annual figure on record is 43.9% in fiscal 2019.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-98.2%+536.0
FY2024Dec 31, 2024-634.2%+13630.7
FY2023Dec 31, 2023-14265.0%+58224.3
FY2022Dec 31, 2022-72489.2%−43264.4
FY2021Dec 31, 2021-29224.8%−29025.6
FY2020Dec 31, 2020-199.2%−243.1
FY2019Dec 31, 201943.9%+207.3
FY2018Dec 31, 2018-163.4%−20.9
FY2017Dec 31, 2017-142.5%+18.0
FY2016Dec 31, 2016-160.5%−161.6
FY2015Dec 31, 20151.1%+440.3
FY2014Dec 31, 2014-439.2%+4168.0
FY2013Dec 31, 2013-4607.2%+5348.3
FY2012Dec 31, 2012-9955.5%−3784.8
FY2011Dec 31, 2011-6170.6%−4220.4
FY2010Dec 31, 2010-1950.2%−1109.5
FY2009Dec 31, 2009-840.7%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-3835.3%−3848.2
Q1 FY2026Mar 31, 2026-4.7%+2030.1
Q4 FY2025Dec 31, 2025-269.1%−145.8
Q3 FY2025Sep 30, 2025-85.9%+3553.7
Q2 FY2025Jun 30, 202512.9%+3373.8
Q1 FY2025Mar 31, 2025-2034.8%+1977.0
Q4 FY2024Dec 31, 2024-123.3%+6534.4
Q3 FY2024Sep 30, 2024-3639.6%+26996.8
Q2 FY2024Jun 30, 2024-3360.9%+10594.9
Q1 FY2024Mar 31, 2024-4011.8%+125746.6
Q4 FY2023Dec 31, 2023-6657.7%+101478.0
Q3 FY2023Sep 30, 2023-30636.4%+28581.5
Q2 FY2023Jun 30, 2023-13955.8%+54635.6
Q1 FY2023Mar 31, 2023-129758.3%+51170.2
Q4 FY2022Dec 31, 2022-108135.7%−8300.9
Q3 FY2022Sep 30, 2022-59217.9%−51543.2
Q2 FY2022Jun 30, 2022-68591.4%+8590.1
Q4 FY2021Dec 31, 2021-180928.6%−177180.8
Q3 FY2021Sep 30, 2021-99834.8%−101141.3
Q2 FY2021Jun 30, 2021-7674.8%−6970.0
Q1 FY2021Mar 31, 2021-77181.5%−76400.9
Q4 FY2020Dec 31, 2020-3747.7%−3206.7
Q3 FY2020Sep 30, 20201306.5%+1230.2
Q2 FY2020Jun 30, 2020-704.8%−513.2
Q1 FY2020Mar 31, 2020-780.6%−591.0
Q4 FY2019Dec 31, 2019-541.0%−468.6
Q3 FY2019Sep 30, 201976.3%+405.4
Q2 FY2019Jun 30, 2019-191.5%+27.9
Q1 FY2019Mar 31, 2019-189.6%−40.9
Q4 FY2018Dec 31, 2018-72.4%+13.0
Q3 FY2018Sep 30, 2018-329.1%−225.8
Q2 FY2018Jun 30, 2018-219.4%+57.7
Q1 FY2018Mar 31, 2018-148.6%+71.3
Q4 FY2017Dec 31, 2017-85.4%+50.6
Q3 FY2017Sep 30, 2017-103.4%+22.7
Q2 FY2017Jun 30, 2017-277.1%–
Q1 FY2017Mar 31, 2017-220.0%–
Q4 FY2016Dec 31, 2016-136.0%–
Q3 FY2016Sep 30, 2016-126.0%–

More Lexicon Pharmaceuticals figures

See a number that looks wrong?